Indaptus Therapeutics (INDP) Net Equity Issued and Repurchased (2020 - 2025)
Indaptus Therapeutics (INDP) posted quarterly Net Equity Issued and Repurchased of -$4.7 million for Q4 2025, down 318.12% year-over-year from $2.1 million in Q4 2024, and down 306.97% quarter-over-quarter from $2.2 million in Q3 2025.
Indaptus Therapeutics (INDP) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Indaptus Therapeutics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$4.7 million for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased fell 318.12% year-over-year to -$4.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 70.04% YoY), while the FY2025 annual figure was $1.7 million, down 68.42% from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at -$4.7 million, down from $2.2 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $3.5 million in Q1 2025, with the low at -$4.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.66 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 575,069.00 |
| Jun 30, 2025 | 575,069.00 |
| Mar 31, 2025 | 3.48 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 39,544.00 |
| Jun 30, 2024 | 39,544.00 |
| Mar 31, 2024 | 336,044.00 |
| Mar 31, 2024 | 336,044.00 |
| Mar 31, 2020 | 421,000.00 |
| Mar 31, 2020 | 421,000.00 |